Mereo BioPharma Group PLC (NASDAQ: MREO) has recently released its financial results for the first quarter of 2025, revealing both challenges and opportunities for the biopharmaceutical company focused on developing innovative therapeutics for rare diseases.
Key points and statistics:
Net Loss: ...